Drug Trial Radar · NCT03461757
Trial in Adult Subjects With Acute Migraines
Last checked: Nov 20, 2026Latest source record: Feb 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,811
Actual
Start
Feb 27, 2018
Primary completion
Oct 8, 2018
Study completion Oct 15, 2018
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Mar 12, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant ODT) versus placebo in subjects with Acute Migraines.
Conditions
- Migraine, With or Without Aura
Interventions
RimegepantDrug
75 mg ODT QD
PlaceboDrug
Placebo ODT to match rimegepant dose QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 hours post-dose
- Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 hours post-dose
Locations
69 sites in 1 country. Site status is shown where the registry gives one.
Coastal Clinical Research, LLC
Mobile, Alabama
Clinical Research Consortium, An AMR Company
Tempe, Arizona
Radiant Research, Inc.
Tucson, Arizona
Baptist Health Center for Clinical Research
Little Rock, Arkansas
Woodland International Research Group, LLC
Little Rock, Arkansas
Pharmacology Research Institute
Encino, California
eStudySite
La Mesa, California
Collaborative Neuroscience Network, LLC
Long Beach, California
Pharmacology Research Institute
Los Alamitos, California
Synergy San Diego
National City, California
Pharmacology Research Institute
Newport Beach, California
Optimus Medical Group
San Francisco, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Yale University
New Haven, Connecticut
Ki Health Partners LLC DBA New England Institute for Clinical Research
Stamford, Connecticut
MD Clinical
Hallandale, Florida
AGA Clinical Trials
Hialeah, Florida
Multi-Specialty Research Associates, Inc.
Lake City, Florida
Qps Mra, Llc
Miami, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
Ormond Medical Arts Pharmaceutical Research
Ormond Beach, Florida
Synexus
Atlanta, Georgia
iResearch Atlanta, LLC
Decatur, Georgia
Meridian Clinical Research, LLC
Savannah, Georgia
Heartland Research Associates LLC
Augusta, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Cresent City Headache and Neurology Center LLC
Chalmette, Louisiana
New Orleans Center for Clinical Research
New Orleans, Louisiana
DelRicht Research
New Orleans, Louisiana
Boston Clinical Trials
Boston, Massachusetts
NECCR Primacare Research, LLC
Fall River, Massachusetts
Community Clinical Research Network/Milford Emergency Associates, Inc
Marlborough, Massachusetts
Clinical Research Institute, Inc.
Minneapolis, Minnesota
Clinical Research Institute, Inc.
Plymouth, Minnesota
StudyMetrix Research, LLC
City of Saint Peters, Missouri
Center for Pharmaceutical Research
Kansas City, Missouri
Sundance Clinical Research
St Louis, Missouri
Meridian Clinical Research, LLC
Norfolk, Nebraska
Hassman Research Institute
Berlin, New Jersey
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.